Fertility and Sterility
Volume 92, Issue 1 , Pages 393.e15-393.e17 , July 2009

Spontaneous intrauterine pregnancy after unilateral placement of tubal occlusive microinsert

  • Kenan Omurtag, M.D.

      Affiliations

    • Corresponding Author InformationReprint requests: Kenan Omurtag, M.D., 69 Jesse Hill Jr. Drive, Department of Gynecology and Obstetrics, Room 412, Atlanta, Georgia 30303 (FAX: 404-521-3589).
  • ,
  • Samuel Pauli, M.D.
  • ,
  • Donna Session, M.D.

Received 18 January 2009 ,Revised 5 March 2009 ,Accepted 10 March 2009.

References 

  1. Miller JH, Weinberg RK, Canino NL, Klein NA, Soules MR. The pattern of infertility diagnoses in women of advanced reproductive age. Am J Obstet Gynecol. 1999;181:952
  2. Strandell A, Waldenstrom U, Nilsson L, Hamberger L. Hydrosalpinx reduced in vitro fertilization/embryo transfer pregnancy rates. Hum Reprod. 1994;9:861–863
  3. Kassabji M, Sims JA, Butler L, Muasher SJ. Reduced pregnancy outcome in patients with unilateral or bilateral hydrosalpinx after in vitro fertilization. Eur J Obstet Gynecol Reprod Biol. 1994;56:129
  4. Andersen AN, Yue Z, Meng FJ, Petersen K. Low implantation rate after in-vitro fertilization in patients with hydrosalpinges diagnosed by ultrasonography. Hum Reprod. 1994;9:1935–1938
  5. Vandromme J, Chasse E, Lejeune B, van Rysselborge M, Delvigne A, Leroy F. Hydrosalpinges in in-vitro fertilization: an unfavourable prognostic feature. Hum Reprod. 1995;10:576–579
  6. Mukherjee T, Copperman AB, McCaffrey C, Cook CA, Bustillo M, Obasaju MF. Hydrosalpinx fluid has embryotoxic effects on murine embryogenesis: a case for prophylactic salpingectomy. Fertil Steril. 1996;66:851–853
  7. Kontoravdis A, Makrakis E, Pantos K, Botsis D, Deligeoroglou E, Creatsas G. Proximal tubal occlusion and salpingectomy result in similar improvement in in-vitro fertilization outcome in patients with hydrosalpinx. Fertil Steril. 2006;6:1642–1649
  8. Camus E, Poncelet C, Goffinet F, Wainer B, Merlet F, Nisand I, et al. Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies. Hum Reprod. 1999;14:1243
  9. Johnson NP, Mak W, Sowter MC. Surgical treatment for tubal disease in women due to undergo in vitro fertilization. Cochrane Database Syst Rev. 2004;3:CD002125
  10. Rosenfield R, Stones R, Coates A, Matteri RK, Hesla JS. Proximal occlusion of hydrosalpinx by hysteroscopic placement of microinsert before in vitro fertilization-embryo transfer. Fertil Steril. 2005;5:1547.e11–e14
  11. Galen DI, McWatters J. Utilization of the Essure® microinsert for the treatment of hydrosalpinx prior to in vitro fertilization. Fertil Steril. 2007;88:O–42
  12. Kerin JF, Cattanach S. Successful pregnancy outcome with the use of in vitro fertilization after Essure® hysteroscopic sterilization. Fertil Steril. 2007;5:1212e.1–4
  13. Kerin JF, Cooper JM, Price T, Van Herendael BJ, Cayuela-Font E, Cher D, et al. Hysteroscopic sterilization using a microinsert device: results of a multicentre phase II study. Hum Reprod. 2003;18:1223–1230
  14. Hitkari JA, Singh SS, Shapiro HM, Leyland N. Essure® treatment of hydrosalpinges. Fertil Steril. 2007;88:1663–1666
  15. Moses AW, Burgis JT, Bacon JL, Risinger J. Pregnancy after Essure® placement: report of two cases. Fertil Steril. 2008;89:724.e9–11
  16. Kerin JF. Pregnancies in women who have undergone the Essure® hysteroscopic sterilization procedure: a summary of 37 cases. J Minim Invasive Gynecol. 2005;12:28
  17. Kerin JF, Munday D, Ritossa M, Rosen D. Tissue encapsulation of the proximal Essure® micro-insert from the uterine cavity following hysteroscopic sterilization. J Minim Invasive Gynecol. 2007;14:202–204

 K.O. has nothing to disclose. S.P. has nothing to disclose. D.S. has nothing to disclose.

PII: S0015-0282(09)00612-8

doi: 10.1016/j.fertnstert.2009.03.047

Fertility and Sterility
Volume 92, Issue 1 , Pages 393.e15-393.e17 , July 2009